TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06291506

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation of heart atrial tissue.
Description: Ablation with radiofrequency, advances techniques: contact force-guided, improved tissue temperature sensors, automark algorithms.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Radiofrequency ablation of heart atrial tissue.
Description: Ablation with radiofrequency, advances techniques: contact force-guided, improved tissue temperature sensors, automark algorithms.
Study: NCT05220371

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Collagen
Description: Participants ingest 15 grams of either specific collagen peptides or Placebo daily

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Concurrent training
Description: Both arms undergo a 12-week trainingintervention 3x/week

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Concurrent training
Description: Both arms undergo a 12-week trainingintervention 3x/week
Study: NCT05471206

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Milk and SmartPill intakes
Description: During visit V2, the subject will ingest the SmartPill capsule. Then, subjects will drink milk.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Milk and SmartPill intakes
Description: During visit V2, the subject will ingest the SmartPill capsule. Then, subjects will drink milk.
Study: NCT05730374

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Benson's Relaxation technique
Description: Each child in the study group had an individual interview with researchers, who demonstrated the Benson relaxation technique while teaching them. The child was then asked to demonstrate it. sit quietly in a comfortable position in separate room., close eyes, deeply relax all muscles, beginning at the feet and progressing up to the face and breathe through nose. Become aware of breathing pattern. As breathes out, say the word one silently to child. For example, breathe in, and then out, say one, in and out, and repeat one. Breathe easily and naturally. It is Continue for 10 minutes and repeated two times.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Music therapy
Description: * The child lessen to a Mozart's music, which is played before and throughout the blood transfusion procedure. Ambient noise can be reduced by using headphones. As a result, it is easier to see how the intervention has succeeded.~* This intervention was done using an MP3 player during the blood transfusion procedure and immediately following the completion of the intervention to prevent the transmission of infections headphones were cleaned with disinfectant after each -use.
Study: NCT02942706

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cetuximab
Description: anti-EGFR monoclonal antibody

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cetuximab
Description: anti-EGFR monoclonal antibody

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: mFOLFOX6
Description: Oxaliplatin+LV5FU2

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: FOLFIRI
Description: Irinotecan+LV5FU2
Study: NCT04944381

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SARS-Cov-2 mRNA vaccine immunization
Description: The 98 participants will be inoculated with one dose SARS-Cov-2 mRNA vaccine from Stemirna Therapeutics Co., Ltd and .

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Inactivated SARS-Cov-2 vaccine immunization
Description: The 14 participants will be inoculated with one dose inactivated SARS-Cov-2 vaccine from institute of medical biology, Chinese academy of medical sciences(IMBCAMS).
Study: NCT05165550

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Elsulfavirine
Description: Elsulfavirine (Elpida®) 20 mg capsules for oral administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Elsulfavirine
Description: Elsulfavirine (Elpida®) 20 mg capsules for oral administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Elsulfavirine
Description: Elsulfavirine (Elpida®) 20 mg capsules for oral administration
Study: NCT04822233

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hall Technique (HT)
Description: Prior to each restoration, a bacterial sample of the lesion will be obtained with a cotton swap and dispensed in a transport medium for microbial analyses.The preformed metal crown (PMC) will placed without local anesthetic and without crimping or trimming. When the contact points are tight, an orthodontic elastic separator will be placed for 2 hours prior to PMC placement. The PMCs will be cemented with glass ionomer Ketac cem.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Modified Hall Technique (MHT)
Description: Prior to each restoration, a bacterial sample of the lesion will be obtained with a cotton swab and dispensed in a transport medium for microbial analyses.This group will in addition to all the procedures for the Hall will have the Caries lesions treated with 30% Silver Diamine Fluoride (SDF) before cementation of the stainless-steel crowns.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Technique (CT)
Description: Prior to each restoration, a bacterial sample of the lesion will be obtained with a cotton swab and dispensed in a transport medium for microbial analyses. Conventional occlusal, proximal slicing and when necessary buccal and lingual surfaces will be carried out under local anesthesia and dental dam isolation local anesthesia.The PMC will be trimmed and crimped at the gingival margin to improve the fit, and cemented with Ketac cem.
Study: NCT06409117

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Percutaneous coronary intervention
Description: Percutaneous coronary intervention with scaffold implantation in patients with NSTE/ACS

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Percutaneous coronary intervention
Description: Percutaneous coronary intervention with scaffold implantation in patients with NSTE/ACS
Study: NCT05156944

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: physiotherapeutic intervention
Description: The intervention consists of a brief physiotherapeutic assessment, the short physical performance battery, a brief information on the expected course of the condition, a check of fall hazards at home using the Bundesamt für Unfallverhütung (bfu) checklist, and instructions on self-management (eg. staying active, adaptation of behavior and surrounding at home). Additionally, two exercises for daily self-guided therapy will be instructed, namely, sit-to-stand and balance performance exercises.
Study: NCT05604144

Intervention type: DEVICE
Group type: OTHER
Intervention: Cryoanalgesia (iovera°®)
Description: iovera°® treatment will be administered via ultrasound guidance to 1-2 branches of the dorsal/digital/proper nerve/s that innervate the Morton's neuroma. The treatment will be completed one time per subject.
Study: NCT06069180

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Busulfan
Description: Conditioning regimens were Bu/Flu/Cy/ATG or Bu/Cy/ATG, depending on the patient's risk factors of regimen related cardiotoxicity.

Intervention type: DRUG
Group type: OTHER
Intervention: Flu/Cy/ATG or Cy/ATG
Description: Conditioning regimens were Flu/Cy/ATG or Cy/ATG, depending on the patient's risk factors of regimen related cardiotoxicity.
Study: NCT05179278

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Post-surgical nurse follow-up
Description: Follow-up face-to-face consultation or follow-up telephone consultation a month after the intervention and telephone consultation at one year

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Post-surgical nurse follow-up
Description: Follow-up face-to-face consultation or follow-up telephone consultation a month after the intervention and telephone consultation at one year
Study: NCT06199908

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AMT-562
Description: Administered AMT-562 for injection intravenously
Study: NCT06000930

Intervention type: DIAGNOSTIC_TEST
Intervention: Troponin fragmentation
Description: laboratory test from blood sample

Intervention type: DIAGNOSTIC_TEST
Intervention: Troponin fragmentation
Description: laboratory test from blood sample
Study: NCT06233435

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: PADSS
Description: Observe PADSS after total knee arthroplasty at 6 and 24 hours

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: PADSS
Description: Observe PADSS after total knee arthroplasty at 6 and 24 hours
Study: NCT05265481

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Tourniquet
Description: The investigators will apply a pressure cuff tourniquet inflated to 60 mmHg

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Tourniquet
Description: The investigators will apply a pressure cuff tourniquet inflated to 60 mmHg

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Tourniquet
Description: The investigators will apply a pressure cuff tourniquet inflated to 60 mmHg

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Manual Tapping
Description: The investigators will apply tapping directly over the vein manually to increase the vein dimension.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Device tapping
Description: The investigators will apply tapping directly over the vein with a massage device to increase the vein dimension.
Study: NCT05741645

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kinesiotaping
Description: During the kinesio taping of the erector spina vs multifidus muscles, the patient is in a standing position. Kinesiotape is applied with 50% tension and stays in the patient for 30 minutes.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham Kinesiotaping
Description: The elastic taping will be randomly applied to a place outside the area to be measured, without stretching, and without causing any effect.
Study: NCT05684588

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Magnetic Resonance
Description: After enrollment a Magnetic Resonance without medium contrast, at 1 year from previous hospitalization
Study: NCT06180668

Intervention type: PROCEDURE
Intervention: Trauma Laparotomy
Description: Emergency abdominal surgery through midline incision to access abdominal and / or pelvic organs, to access identified injuries or exploratory diagnostic reasons
Study: NCT06057610

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-A1811 Injection
Description: SHR-A1811 Injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-A1811 Injection ； Pertuzumab Injection
Description: SHR-A1811 Injection ； Pertuzumab Injection

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Trastuzumab Injection；Pertuzumab Injection ； Docetaxel Injection
Description: Trastuzumab Injection；Pertuzumab Injection ； Docetaxel Injection
Study: NCT04645823

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fentanyl Citrate
Description: Fentanyl citrate 20 µg in 2 ml of saline injected into csf
Study: NCT05302895

Intervention type: DEVICE
Intervention: All-in-one health monitoring device
Description: The staff will use the new monitoring device to carry out the health monitoring on every day during the 12-week period. After each round of health monitoring by the traditional and the new devices, the staff will need to fill in log sheets designed by HKU to document the time consumed for the entire process.
Study: NCT05770297

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Propolis
Description: intervention will use propolis extract (liquid-based) with 1 drop/10kgBW/times, 2 times in a day for 12 weeks. propolis will be given to intervention group

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: intervention will use placebo with 1 drop/10kgBW/times, 2 times in a day for 12 weeks. propolis will be given control group
Study: NCT06084000

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Drug-coated balloon (Bingo© [Paclitaxel-coated Balloon], Yinyi Ltd., China)
Description: * Patients treated with DCB will receive dual antiplatelet therapy (DAPT, aspirin plus P2Y12 inhibitor) for 1-3 months, followed by long-term single antiplatelet therapy (SAPT, aspirin or P2Y12 inhibitor).~* Patients with bailout stenting will generally receive DAPT for 6 months unless deemed as with high ischemic and/or bleeding risks (see special consideration in Drug-eluting stent Arm), and then followed by long-term SAPT.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Drug-eluting stent
Description: * Patients treated with DES will generally receive DAPT for 6 months unless deemed as with high ischemic and/or bleeding risks (see special consideration below), and then followed by long-term SAPT.~* Special consideration:~  1. Patients will take additional assessment (both DAPT score and PRECISE-DAPT score) to determine their personalized duration of DAPT.~ 2. The duration of DAPT is extended to 12 months for patients diagnosed as acute coronary syndrome within 12 months.~ 3. If anticoagulation is indicated, patient will receive a short-term triple antithrombotic therapy (generally 1 to 4 weeks), followed by a variable length of dual antithrombotic therapy (oral anticoagulation (OAC) plus a single antiplatelet agent, preferably clopidogrel) and subsequent long-term OAC mono-therapy. The duration of dual antithrombotic therapy is determined by bleeding risks (HAS-BLED score) according to current guidelines.
Study: NCT04719221

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Evolocumab
Description: The maximum dose of combined cholesterol therapy (Statin + Ezetimibe) is prescribed for 2 months, and a cholesterol test is performed in an outpatient clinic to ensure that LDL-Cholesterol \<70mg/dL is met. Patients who do not meet the criteria are randomized to maintain current treatment or receive additional Evolocumab according to randomization.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Evolocumab
Description: The maximum dose of combined cholesterol therapy (Statin + Ezetimibe) is prescribed for 2 months, and a cholesterol test is performed in an outpatient clinic to ensure that LDL-Cholesterol \<70mg/dL is met. Patients who do not meet the criteria are randomized to maintain current treatment or receive additional Evolocumab according to randomization.

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: NIRS IVUS
Description: near-infrared spectroscopy

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: NIRS IVUS
Description: near-infrared spectroscopy
Study: NCT04645823

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine 1% Injectable Solution
Description: Fentanyl citrate 100µg and lidocaine hydrochloride 80 mg in 10 ml volume

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fentanyl Citrate
Description: Fentanyl citrate 100µg and lidocaine hydrochloride 80 mg in 10 ml volume
Study: NCT05813951

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Linezolid
Description: linezolid either continues infusion or standard intermittent dose
Study: NCT04754113

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: prone position
Description: patient was helped into the prone position, patient received instructions of end expiratory occlusion lasting at least 10 seconds and, 1 seconds after the start, a bolus of 10 mL of 5% NaCl solution was injected via the central venous catheter
Study: NCT06312605

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Injectable applied vitamin C
Description: Surgical gingival depigmentation is done for all participants, after then they receive injectable vitamin C

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Topical applied Vitamin C
Description: Surgical gingival depigmentation is done for all participants, after then they are instructed to apply topical vitamin C

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Surgical depigmentation only
Description: Surgical gingival depigmentation only without any drug
Study: NCT05072756

Intervention type: OTHER
Intervention: Applying a questionnaire
Description: The participants have to answer a questionnaire addressing their opinion on menopausal hormone replacement therapy
Study: NCT04714489

Intervention type: OTHER
Intervention: NO.
Description: NO.
Study: NCT06167278

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Indirect bonding with two different digital bracket bonding transfer tray
Description: To achieve more precise and predictable result is the common aim in contemporary treatment. Digital indirect bonding (IDB) is used for this purpose in orthodontic treatment. The aim of this study is to compare the transfer accuracy of two different IDB trays.~Digital IDB was performed on a total of 30 patients, using one of the two designs: shell and bar trays; with 15 patients in each group. Trays were designed with the Appliance Designer software (3Shape A/S, Copenhagen, Denmark) as shell and bar types.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Indirect bonding with two different digital bracket bonding transfer tray
Description: To achieve more precise and predictable result is the common aim in contemporary treatment. Digital indirect bonding (IDB) is used for this purpose in orthodontic treatment. The aim of this study is to compare the transfer accuracy of two different IDB trays.~Digital IDB was performed on a total of 30 patients, using one of the two designs: shell and bar trays; with 15 patients in each group. Trays were designed with the Appliance Designer software (3Shape A/S, Copenhagen, Denmark) as shell and bar types.
Study: NCT06161857

Intervention type: OTHER
Intervention: No intervention
Description: There is no intervention this is an observational study to develop a diagnostic test

Intervention type: OTHER
Intervention: No intervention
Description: There is no intervention this is an observational study to develop a diagnostic test

Intervention type: OTHER
Intervention: No intervention
Description: There is no intervention this is an observational study to develop a diagnostic test

Intervention type: OTHER
Intervention: No intervention
Description: There is no intervention this is an observational study to develop a diagnostic test
Study: NCT06094972

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Adolescent Community Reinforcement Approach, A-CRA
Description: A-CRA consists of eighteen treatment modules/procedures that is delivered in weekly sessions over 12-14 weeks. The overarching goal is to decrease substance use behaviours and other related, problematic behaviours such as acting out when experiencing anger, and to increase prosocial and sober behaviours, relationships and activities. The procedures are: 1) Introduction to A-CRA/treatment agreement, 2) Happiness scale and treatment goals, 3) Homework, 4) Systematic encouragement, 5) Functional analysis of substance use behaviour, 6) Functional analysis of prosocial/sober behaviour, 7) Increasing prosocial activities, 8) Drink/drug refusal, 9) Relapse prevention, 10) Sobriety sampling, 11) Communication skills, 12) Problem-solving, 13) Caregiver sessions, 14) Relationship skills, 15) Couple relationship skills, 16) Job-seeking skills, 17) Anger management, 18) Medication adherence and monitoring. Youths' individual goals and problems guide treatment planning.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: TAU
Description: Standard care is defined as the interventions and treatments adolescents are usually offered and undergo in institutional care in Sweden. These are Motivational Interviewing, MI, Cognitive Behavioral Therapy, CBT, Aggression Replacement Therapy, ART or Acceptance and Commitment Therapy, ACT and PULS, a program for reducing violence and criminal behavior. Also, individually tailored interventions will be included, such as counselling or other psychological interventions. TAU will be thoroughly registered during the study since the sites in the trial differs slightly in what they offer.
Study: NCT06415162

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cooling Pillowcases
Description: No intervention will be given to the patients in the control group.
Study: NCT06308146

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Bacillus subtilis ATCC 122264
Description: One capsule (5 billion CFU) per day for 8 weeks.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: One capsule per day for 8 weeks.
Study: NCT06508437

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Influenza Vaccination
Description: Standard Dose QIV (15µg Hemagglutinin) - VaxigripTetra Suspension for injection, 0,5ml prefilled syringe
Study: NCT05564676

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: flaxseed oil and pomegranate dry extract
Description: The flaxseed oil were yellow capsules with 1.0 g each and the pomegranate dry extract capsules were green with 0.6 g each.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: sunflower oil and microcrystalline cellulose
Description: The sunflower oil were yellow capsules with 1.0 g each and the microcrystalline cellulose capsules were green with 0.6 g each.
Study: NCT05688293

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Connective tissue graft
Description: non-surgical periodontal treatment and connective tissue graft

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Free gingival graft
Description: will receive non-surgical periodontal treatment and partially de-epithelized free gingival graft

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Non surgical
Description: non-surgical periodontal treatment only
Study: NCT05151367

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Text message reminder
Description: Receipt of text messages notifying when the next HPV vaccine dose is due (either first or second)
Study: NCT04323423

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: interrupting sedentary behaviour with light physical activity
Description: replacing sitting with light walking bouts at different frequencies/durations

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: interrupting sedentary behaviour with light physical activity
Description: replacing sitting with light walking bouts at different frequencies/durations
Study: NCT04985240

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Lettuce with no biofortification
Description: Lettuce without any biofortification was assigned to each participant belonging to the control group which ate 100gr every day for 10 days

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Intervention Molibdenum group
Description: Lettuce with Iodine biofortification was assigned to each participant belonging to the intervention group which ate 100gr every day for 10 days